Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
复制标题
DOI:
10.1016/j.stemcr.2021.12.016
复制
发表时间:
2022-02-08
影响因子:
5.9
通讯作者:
Sakata Y
中科院分区:
文献类型:
--
作者:
Inoue H;Nakamura S;Higo S;Shiba M;Kohama Y;Kondo T;Kameda S;Tabata T;Okuno S;Ikeda Y;Li J;Liu L;Yamazaki S;Takeda M;Ito E;Takashima S;Miyagawa S;Sawa Y;Hikoso S;Sakata Y
Loss-of-function mutations in PKP2, which encodes plakophilin-2, cause arrhythmogenic cardiomyopathy (AC). Restoration of deficient molecules can serve as upstream therapy, thereby requiring a human model that recapitulates disease pathology and provides distinct readouts in phenotypic analysis for proof of concept for gene replacement therapy. Here, we generated isogenic induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with precisely adjusted expression of plakophilin-2 from a patient with AC carrying a heterozygous frameshift PKP2 mutation. After monolayer differentiation, plakophilin-2 deficiency led to reduced contractility, disrupted intercalated disc structures, and impaired desmosome assembly in iPSC-CMs. Allele-specific fluorescent labeling of endogenous DSG2 encoding desmoglein-2 in the generated isogenic lines enabled real-time desmosome-imaging under an adjusted dose of plakophilin-2. Adeno-associated virus-mediated gene replacement of PKP2 recovered contractility and restored desmosome assembly, which was sequentially captured by desmosome-imaging in plakophilin-2-deficient iPSC-CMs. Our isogenic set of iPSC-CMs recapitulates AC pathology and provides a rapid and convenient cellular platform for therapeutic development. Generation of isogenic iPSC-CMs with a precise dose of plakophilin-2 Modeling reduced contractility and impaired desmosome assembly using iPSC-CMs Generation of isogenic iPSC-CMs for desmosome-imaging Proof of concept of PKP2 replacement using isogenic plakophilin-2-deficient iPSC-CMs In this article, Higo and colleagues generate isogenic iPS cell-derived cardiomyocytes (iPSC-CMs) with precisely adjusted expression of PKP2, modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency. PKP2 gene replacement recovered contractility and restored desmosome assembly, which was sequentially captured by desmosome imaging. The isogenic iPSC-CMs recapitulate the pathology of arrhythmogenic cardiomyopathy and provide a rapid and convenient cellular platform for therapeutic development.
登录
查看更多内容
影响因子:
4.6
作者:
Ishizu T;Higo S;Masumura Y;Kohama Y;Shiba M;Higo T;Shibamoto M;Nakagawa A;Morimoto S;Takashima S;Hikoso S;Sakata Y
通讯作者:
Sakata Y
影响因子:
4.6
作者:
Kohama Y;Higo S;Masumura Y;Shiba M;Kondo T;Ishizu T;Higo T;Nakamura S;Kameda S;Tabata T;Inoue H;Motooka D;Okuzaki D;Takashima S;Miyagawa S;Sawa Y;Hikoso S;Sakata Y
通讯作者:
Sakata Y
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
48
作者:
Burridge, Paul W.;Matsa, Elena;Shukla, Praveen;Lin, Ziliang C.;Churko, Jared M.;Ebert, Antje D.;Lan, Feng;Diecke, Sebastian;Huber, Bruno;Mordwinkin, Nicholas M.;Plews, Jordan R.;Abilez, Oscar J.;Cui, Bianxiao;Gold, Joseph D.;Wu, Joseph C.
通讯作者:
Wu, Joseph C.
影响因子:
3.5
作者:
Ramond, F.;Janin, A.;Millat, G.
通讯作者:
Millat, G.